Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials
- PMID: 29334927
- PMCID: PMC5769334
- DOI: 10.1186/s12871-018-0472-1
Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials
Abstract
Background: Dexmedetomidine has been shown to confer direct renoprotection by stabilizing the sympathetic system, exerting anti-inflammatory effects and attenuating ischemia/reperfusion (I/R) injury in preclinical studies. Results from clinical trials of dexmedetomidine on acute kidney injury (AKI) following adult cardiac surgery are controversial.
Methods: We searched EMBASE, PubMed, and Cochrane CENTRAL databases for randomized controlled trials (RCTs) comparing the renal effect of dexmedetomidine versus placebo or other anesthetic drugs in adult patients undergoing cardiac surgery. The primary outcome was the incidence of AKI. The secondary outcomes were mechanical ventilation (MV) duration, intensive care unit (ICU) stay and hospital length of stay(LOS), and postoperative mortality (in-hospital or within 30 days).
Results: Ten trials with a total of 1575 study patients were selected. Compared with controls, dexmedetomidine significantly reduced the incidence of postoperative AKI [68/788 vs 97/787; odds ratio(OR), 0.65; 95% confidence interval (CI), 0.45-0.92; P = 0.02; I2 = 0.0%], and there was no difference between groups in postoperative mortality (4/487 vs 11/483; OR, 0.43; 95% CI, 0.14-1.28; P = 0.13; I2 = 0.0%), MV duration [in days; n = 1229; weighted mean difference(WMD), -0.22; 95% CI, -2.04 to 1.70; P = 0.81], ICU stay (in days; n = 1363; WMD, -0.85; 95% CI, -2.14 to 0.45; P = 0.20), and hospital LOS (in days; n = 878; WMD, -0.24; 95% CI, -0.71 to 0.23; P = 0.32).
Conclusions: Perioperative administration of dexmedetomidine in adult patients undergoing cardiac surgery may reduce the incidence of postoperative AKI. Future trials are needed to determine the dose and timing of dexmedetomidine in improving outcomes, especially in patients with decreased baseline kidney function.
Keywords: Acute kidney injury; Cardiac surgery; Dexmedetomidine; Meta-analysis.
Conflict of interest statement
Ethics approval and consent to participate
This meta-analysis was approved by the Institutional Review Board in Shijitan Hospital, Capital Medical University, Beijing.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures







Similar articles
-
Does dexmedetomidine reduce the risk of acute kidney injury after cardiac surgery? A meta-analysis of randomized controlled trials.Braz J Anesthesiol. 2024 May-Jun;74(3):744446. doi: 10.1016/j.bjane.2023.07.003. Epub 2023 Jul 14. Braz J Anesthesiol. 2024. PMID: 37453497 Free PMC article. Review.
-
Dexmedetomidine improves the outcomes in paediatric cardiac surgery: a meta-analysis of randomized controlled trials.Interact Cardiovasc Thorac Surg. 2018 May 1;26(5):852-858. doi: 10.1093/icvts/ivy043. Interact Cardiovasc Thorac Surg. 2018. PMID: 29522148
-
Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.Am J Cardiovasc Drugs. 2020 Jun;20(3):271-281. doi: 10.1007/s40256-019-00380-2. Am J Cardiovasc Drugs. 2020. PMID: 31724106
-
Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.Am J Kidney Dis. 2016 Mar;67(3):408-16. doi: 10.1053/j.ajkd.2015.09.015. Epub 2015 Oct 27. Am J Kidney Dis. 2016. PMID: 26518388
-
Impact of Dexmedetomidine Dosing and Timing on Acute Kidney Injury and Renal Outcomes After Cardiac Surgery: A Meta-Analytic Approach.Ann Pharmacother. 2025 Apr;59(4):319-329. doi: 10.1177/10600280241271098. Epub 2024 Aug 20. Ann Pharmacother. 2025. PMID: 39164825
Cited by
-
Effect of dexmedetomidine for prevention of acute kidney injury after cardiac surgery: an updated systematic review and meta-analysis.Ren Fail. 2022 Dec;44(1):1150-1159. doi: 10.1080/0886022X.2022.2097923. Ren Fail. 2022. PMID: 35834360 Free PMC article.
-
The effect of repetitive exposure to intravenous anesthetic agents on the immunity in mice.Int J Med Sci. 2020 Feb 4;17(4):428-436. doi: 10.7150/ijms.41899. eCollection 2020. Int J Med Sci. 2020. PMID: 32174773 Free PMC article.
-
[Prevention of acute kidney injury in critically ill patients : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].Med Klin Intensivmed Notfmed. 2018 Jun;113(5):358-369. doi: 10.1007/s00063-018-0413-2. Epub 2018 Mar 28. Med Klin Intensivmed Notfmed. 2018. PMID: 29594317 Review. German.
-
Perioperative Renoprotection: General Mechanisms and Treatment Approaches.Anesth Analg. 2020 Dec;131(6):1679-1692. doi: 10.1213/ANE.0000000000005107. Anesth Analg. 2020. PMID: 33186157 Free PMC article. Review.
-
Renal resistive index as a biomarker for acute kidney injury in aortic valve surgery.J Thorac Dis. 2018 Nov;10(Suppl 33):S4010-S4012. doi: 10.21037/jtd.2018.09.45. J Thorac Dis. 2018. PMID: 30631541 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical